Mesoblast
MESO
72 hedge funds and large institutions have $37.9M invested in Mesoblast in 2025 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 19 increasing their positions, 21 reducing their positions, and 11 closing their positions.
45% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 11
30% more call options, than puts
Call options by funds: $7.27M | Put options by funds: $5.59M
6% more funds holding
Funds holding: 68 → 72 (+4)
2.4% more ownership
Funds ownership: 0.31% → 2.72% (+2.4%)
10% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 21
23% less capital invested
Capital invested by funds: $49.2M → $37.9M (-$11.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$1.77M |
| 2 |
PM
Penbrook Management
New York
|
+$982K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$848K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$599K |
| 5 |
Two Sigma Investments
New York
|
+$372K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$4.62M |
| 2 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$1.87M |
| 3 |
Group One Trading
Chicago,
Illinois
|
-$676K |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$669K |
| 5 |
BlackRock
New York
|
-$651K |
MESO Hedge Fund Activity: Q2 2025 in Review
72 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Mesoblast (MESO) for Q2 2025, worth a combined $37.9M — down 23% from $49.2M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new MESO positions and 11 closed out — a net gain of 5 holders — while 19 added to existing stakes and 21 trimmed.
The largest buyer was Goldman Sachs, adding an estimated $1.77M. The largest seller was Citadel Advisors, cutting an estimated $4.62M.
- 72 institutional investors held Mesoblast (MESO) as of Q2 2025, up from 68 in Q1 2025.
- Funds reported $37.9M of Mesoblast stock for Q2 2025, down 23% quarter-over-quarter.
- 16 funds opened new Mesoblast positions in Q2 2025 and 11 closed out, a net change of +5 holders.
- The largest Mesoblast buyer in Q2 2025 was Goldman Sachs, an estimated $1.77M added.
- The largest Mesoblast seller in Q2 2025 was Citadel Advisors, an estimated $4.62M sold.
Based on aggregated 13F filings for Q2 2025.